Synapse - Favorable outcomes among patients with T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era

Favorable outcomes among patients with T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era Meeting Abstract

Authors:	Robin, E. T.; Drill, E.; Batlevi, C. L.; Caron, P.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; Joffe, E.; Kumar, A.; Matasar, M. J.; Noy, A.; Owens, C.; Palomba, M. L.; Rodriguez-Rivera, I.; Straus, D. J.; Vardhana, S.; von Keudell, G. R.; Zelenetz, A. D.; Moskowitz, C. H.; Moskowitz, A. J.
Abstract Title:	Favorable outcomes among patients with T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era
Meeting Title:	62nd Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	136
Issue:	Suppl. 1
Meeting Dates:	2020 Dec 5-8
Meeting Location:	Virtual
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2020-11-05
Language:	English
ACCESSION:	WOS:000607547200051
DOI:	10.1182/blood-2020-136489
PROVIDER:	wos
Notes:	Meeting Abstract: 36 -- Source: Wos